Malignant Hyperthermia in Dogs
Malignant Hyperthermia is a high-severity neurological condition that can affect dogs of all ages and breeds. Malignant hyperthermia is a rare, life-threatening pharmacogenetic disorder triggered by certain anaesthetic agents (halothane, succinylcholine) causing uncontrolled skeletal muscle metabolism and a dangerous rise in body temperature. It is documented across 2 breeds, though prevalence and severity can differ significantly between them. It typically becomes apparent at Any age (anaesthesia-triggered). Early signs to watch for include rapid rise in body temperature under anaesthesia, muscle rigidity, rapid heart rate, and metabolic acidosis. When treatment is required, costs are estimated at £2,000-£5,000 depending on severity, location, and the specific intervention needed. Malignant Hyperthermia has a hereditary component, so health-screening certificates from the breeder are strongly recommended for predisposed breeds. This page covers symptoms, treatment options, and preventive steps — along with breed-specific information where available.
Signs & Symptoms
The following symptoms are commonly associated with Malignant Hyperthermia in dogs. If your dog displays several of these signs, consult your vet promptly — early diagnosis typically leads to better outcomes.
- Rapid rise in body temperature under anaesthesia
- Muscle rigidity
- Rapid heart rate
- Metabolic acidosis
- Cardiac arrhythmias
- Death if untreated
Treatment Overview
Emergency treatment with dantrolene IV, stopping triggering anaesthetic agents, cooling measures, and correction of metabolic disturbances. Prompt recognition and intervention is life-saving.
Typical onset: Any age (anaesthesia-triggered)
Prevention & Screening
While not all cases of Malignant Hyperthermia can be prevented, the following steps reduce risk or enable earlier intervention:
- Genetic test available for dogs with family history
- Inform anaesthetist of at-risk status
- Use total intravenous anaesthesia (TIVA) protocols for known affected dogs
Estimated Treatment Cost
Treatment for Malignant Hyperthermia is estimated at £2,000-£5,000, depending on severity, the specific intervention required, and your location. Costs may be higher for surgical procedures or ongoing management. Comprehensive pet insurance covering hereditary conditions is strongly recommended.
Breeds Affected by Malignant Hyperthermia
The following 1 breed are documented as being susceptible to Malignant Hyperthermia. Click any breed to view breed-specific information about this condition, including prevalence and recommended screening.
Looking for more information? Browse all dog health conditions or explore the health guides for in-depth breed care advice.